World Cancer Institute-CancerVX / OncoVacx Cancer Transformation and Detection via Predictive Epigenomics: Increasing DNAIQ in Redefining Personalized Cancer Therapeutics and Prevention

SAN FRANCISCO, Aug. 4, 2021 /PRNewswire/ -- Nathan Sassover, Founder / CEO of World Cancer Institute Inc. today announced "further clinical developments in enlarging our targeted medical objectives which originated in 2008 and have evolved to a multiplicity of protocols which continue to...

from PR Newswire: https://ift.tt/3rSvJWx